Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Opium Use and Risk of Colorectal Cancer: A Multi-Center Case-Referent Study in Iran Publisher Pubmed



Hadji M1, 2 ; Marzban M3, 4 ; Rashidian H2 ; Naghibzadehtahami A5, 6 ; Gholipour M7 ; Mohebbi E2 ; Safarifaramani R8 ; Seyyedsalehi MS2 ; Hosseini B2, 9 ; Alizadehnavaei R10 ; Rezaianzadeh A11 ; Moradi A7 ; Shahidsales S12 ; Najafi F9, 13 Show All Authors
Authors
  1. Hadji M1, 2
  2. Marzban M3, 4
  3. Rashidian H2
  4. Naghibzadehtahami A5, 6
  5. Gholipour M7
  6. Mohebbi E2
  7. Safarifaramani R8
  8. Seyyedsalehi MS2
  9. Hosseini B2, 9
  10. Alizadehnavaei R10
  11. Rezaianzadeh A11
  12. Moradi A7
  13. Shahidsales S12
  14. Najafi F9, 13
  15. Moazed V14
  16. Haghdoost AA6, 15
  17. Rahimimovaghar A16
  18. Etemadi A17, 18
  19. Malekzadeh R17, 19
  20. Boffetta P20, 21
  21. Weiderpass E9
  22. Kamangar F22
  23. Zendehdel K2, 23
  24. Pukkala E1, 24
Show Affiliations
Authors Affiliations
  1. 1. Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland
  2. 2. Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Public Health, School of Public Health, Bushehr University of Medical Science, Bushehr, Iran
  4. 4. Clinical Research Development Center, The Persian Gulf Martyrs, Bushehr University of Medical Science, Bushehr, Iran
  5. 5. Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  6. 6. Regional Knowledge HUB for HIV/AIDS Surveillance, Research Centre for Modelling in Health, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  7. 7. Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
  8. 8. Research Center for Environmental Determinants of Health, School of Public Health, Kermanshah Medical Sciences University, Kermanshah, Iran
  9. 9. International Agency for Research on Cancer, Lyon, France
  10. 10. Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
  11. 11. Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  12. 12. Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  13. 13. Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
  14. 14. Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
  15. 15. HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  16. 16. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran
  17. 17. Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  18. 18. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States
  19. 19. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  20. 20. Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, United States
  21. 21. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
  22. 22. Department of Biology, School of Computer, Mathematical, and Natural Sciences, Morgan State University, Baltimore, MD, United States
  23. 23. Cancer Biology Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran
  24. 24. Finnish Cancer Registry - Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland

Source: Acta Oncologica Published:2023


Abstract

Background: Opium use has been associated with an increased risk of cancers of the lung, oesophagus, and pancreas, and it was recently classified by the International Agency for Cancer Research as carcinogenic to humans. It is not clear whether opium also increases the risk of colorectal cancer (CRC). The aim of our study was to assess the association between various metrics of opium use and the risk of CRC. Methods: This case-referent study from seven provinces in Iran comprised 848 CRC cases and 3215 referents. Data on opium use (duration, amount, frequency) and potential confounders were collected by trained interviewers. Multivariable unconditional logistic regression models were used to measure odds ratios (OR) adjusted for age, gender, province, marital status, family history of CRC-linked cancers, consumption of red meat, fruits and vegetables, body shape, occupational physical activity, and socioeconomic status. Results: Regular opium consumption was not associated with the risk of CRC (OR 0.9, 95% confidence interval, CI: 0.7, 1.2) compared to subjects who never used opium. However, frequent opium use more than twice a day was associated with an increased risk of CRC compared to non-users of opium (OR: 2.0, 95% CI: 1.1, 3.8; p for quadratic trend 0.008). Conclusion: There seems to be no overall association between opium use and CRC, but the risk of CRC might be increased among persons who use opium many times a day. © 2023 Acta Oncologica Foundation.
Other Related Docs
13. Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma, International Journal of Cancer (2021)
37. Using Causal Diagrams for Biomedical Research, Annals of Emergency Medicine (2023)
39. Validity of Self-Reported Substance Use: Research Setting Versus Primary Health Care Setting, Substance Abuse: Treatment# Prevention# and Policy (2021)
40. Continued Increase in Incidence of Kidney Cancer in Iran and Its 31 Provinces, International Journal of Cancer Management (2024)
41. The Profile of Rafsanjan Cohort Study, European Journal of Epidemiology (2021)